Tag Archives: patentability

Ex parte Ren-Hie Xu – Are Cultured Mammalian Cells Natural Products?

Posted on March 27, 2019 by Warren Woessner

The Examiner in Appeal no. 2017-003416 (Mar. 1, 2019) had rejected this claim as directed to a natural product: “18. An in vitro culture comprising a substantially pure, replenishable population of synchronous primate trophoblast cells, wherein the synchronous primate trophoblast … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | 1 Comment

Knowles and Prosser Posit that the Expansion of s. 101 by the Supreme Court is Unconstitutional

Posted on January 17, 2019 by Warren Woessner

Sherry Knowles (Knowles Intellectual Strategies, LLC) and Anthony Prosser, one of Knowles’ agents have written an engrossing article (18 J. Marshall Rev; Intell. Prop. L. 144 (2018) arguing that the Supreme Court has meandered so far from the statutory language of … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Director Iancu’s IPO Address and Judge Rich

Posted on September 27, 2018 by Warren Woessner

Although Director Iancu’s address primarily aims at the difficulty of determining when a claim is directed to an abstract idea, his precursor guiding light is clearly the late Judge Giles Rich. Notably, Iancu quotes from Judge Rich. These quotes are … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment

Advocates in Alice v. CLS Bank Debate “In the Cloud” in FCBA Webinar

Posted on April 11, 2014 by Warren Woessner

Last Thursday, I managed to miss the webinar sponsored by the Federal Circuit Bar Association on Alice v. CLS Bank, post-oral argument. However, I just finished listening to the audio transcript. It is not easy to summarize an hour-long discussion … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | Leave a comment